Rational Design of Biofunctional Borosilicate Glasses: Tuning Therapeutic Ions and in Vitro Biological Evaluation

Fulei Gao,Tao Liu,Die Hu,Lisheng Xu,Lei Yang,Guocheng Zhu,Xinbo Ding
DOI: https://doi.org/10.1016/j.ceramint.2024.11.256
IF: 5.532
2024-01-01
Ceramics International
Abstract:Introducing therapeutic ions of bioactive glasses as scaffolds is appealing due to attractive architectural biomimicry of bone extracellular matrix and adjustable composition accompanied with soluble ions released for bone regeneration and remodeling. Herein, this strategy was expanded to develop biocomposites of borosilicate glasses incorporated with different therapeutic ions using a facile sol-gel technique and cetyltrimethylammonium bromide (CTAB) as the template. Mediating therapeutic ions (i.e., copper/selenium/strontium at the same content) in a SiO2–B2O3–CaO–P2O5 glassy system is effective and simple method for modifying structural-morphological features and physicochemical characteristics of the bioglasses. In vitro bioactivity measurements revealed that strontium/selenium-doped borosilicate glasses had faster apatite-formation ability compared to copper-doped borosilicate glasses. For in vitro drug release, rhodamine B (RB) storage and release showed that copper-doped borosilicate glasses had high storage capacities (79.42%) and cumulated release rate (87.18% at pH 1.2), and demonstrated sustained pH-sensitive drug release patterns. The RB release profiles also showed two-stage release mechanism following the Korsmeyer-Peppas model during the first release stage (the first 24 h), and the Weibull model during next stage (beyond 24 h). In subsequent bacterial studies, copper-doped borosilicate glasses could effectively inhibit (100% at 2.5 mg mL–1) Escherichia coli and Staphylococcus aureus colonization. In vitro biocompatibility assays also showed that all bioglass samples were biocompatible. According to obtained data, present bicomponent composite strategy may pave the way for the design of bioglasses doped with functional ions tailored to induce biological activity that can heal infectious bone in vivo.
What problem does this paper attempt to address?